Cargando…

Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models

Although T cell-recruiting CD3-binding bispecific antibodies (BiMAb) have been proven to be clinically effective for hematologic malignancies, the success of BiMAb targeting solid tumor-associated antigens (TAA) in carcinomas so far remains poor. We reasoned that provision of co-stimulatory BiMAb in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warwas, Karsten M., Meyer, Marten, Gonçalves, Márcia, Moldenhauer, Gerhard, Bulbuc, Nadja, Knabe, Susanne, Luckner-Minden, Claudia, Ziegelmeier, Claudia, Heussel, Claus Peter, Zörnig, Inka, Jäger, Dirk, Momburg, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415424/ https://www.ncbi.nlm.nih.gov/pubmed/34484225 http://dx.doi.org/10.3389/fimmu.2021.719116

Ejemplares similares

Sequence mutations of the substrate binding pocket of stem cell factor and multidrug resistance protein ABCG2 in renal cell cancer: A possible link to treatment resistance
por: ZOERNIG, INKA, et al.
Publicado: (2013)

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
por: Bashari, Muhammad Hasan, et al.
Publicado: (2016)

Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing
por: Passariello, Margherita, et al.
Publicado: (2019)

A CLDN18.2-Targeting Bispecific T Cell Co-Stimulatory Activator for Cancer Immunotherapy
por: Liang, Jie, et al.
Publicado: (2021)

Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
por: Zitron, Ian M, et al.
Publicado: (2013)

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
por: Weth, R, et al.
Publicado: (2004)

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody
por: Choi, Bryan D, et al.
Publicado: (2013)

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells
por: Melo, Vinicio, et al.
Publicado: (2023)

Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
por: Trinklein, Nathan D., et al.
Publicado: (2019)

Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing
por: Hill, Tyler F., et al.
Publicado: (2023)

Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
por: Strohl, William R., et al.
Publicado: (2019)

Retargeting T Cells for HER2-Positive Tumor Killing by a Bispecific Fv-Fc Antibody
por: Wang, Lei, et al.
Publicado: (2013)

Bispecific T cell engager (BiTE(®)) antibody constructs can mediate bystander tumor cell killing
por: Ross, Sandra L., et al.
Publicado: (2017)

Bispecific T cell engagers kill resistant cells during KRAS-G12C blockade therapy
por: Song, Xinxin, et al.
Publicado: (2022)

Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker.
por: Moldenhauer, G., et al.
Publicado: (1987)

HLA-E Peptide Repertoire and Dimorphism—Centerpieces in the Adaptive NK Cell Puzzle?
por: Rölle, Alexander, et al.
Publicado: (2018)

Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibody
por: Ahmed, Mahiuddin, et al.
Publicado: (2015)

A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells
por: Lund, Maria E., et al.
Publicado: (2020)

In silico SNP analysis of the breast cancer antigen NY-BR-1
por: Kosaloglu, Zeynep, et al.
Publicado: (2016)

Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.
por: Stein, B., et al.
Publicado: (1988)

A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells
por: Aschmoneit, Nadine, et al.
Publicado: (2021)

Nonviral mcDNA-mediated bispecific CAR T cells kill tumor cells in an experimental mouse model of hepatocellular carcinoma
por: Wang, Hezhi, et al.
Publicado: (2022)

T-cell co-stimulatory pathways in autoimmunity
por: Goronzy, Jörg J, et al.
Publicado: (2008)

Shortened Hinge Design of Fab x sdAb-Fc Bispecific Antibodies Enhances Redirected T-Cell Killing of Tumor Cells
por: Huang, Shuyu, et al.
Publicado: (2022)

Stimulatory Interactions between Human Coronary Smooth Muscle Cells and Dendritic Cells
por: Paccosi, Sara, et al.
Publicado: (2014)

Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer
por: Herr, Ingrid, et al.
Publicado: (2012)

Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness
por: Tiwari-Heckler, Shilpa, et al.
Publicado: (2021)

Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022)

Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells
por: Lutz, Sebastian, et al.
Publicado: (2023)

Heat-Killed Lactobacillus brevis Enhances Phagocytic Activity and Generates Immune-Stimulatory Effects through Activating the TAK1 Pathway
por: Jeong†, Minju, et al.
Publicado: (2020)

Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase Expression
por: Werner, Anke, et al.
Publicado: (2017)

Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cells
por: Grugan, Katharine D., et al.
Publicado: (2016)

Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells
por: Hambach, Julia, et al.
Publicado: (2022)

A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells
por: Bozza, Matthias, et al.
Publicado: (2021)

Stimulatory Effect of β-glucans on Immune Cells
por: Kim, Hyung Sook, et al.
Publicado: (2011)

Co-Stimulatory Receptor Signaling in CAR-T Cells
por: Honikel, Mackenzie M., et al.
Publicado: (2022)

Increased stimulatory capacity of antigen presenting cells at the site of autoimmune inflammation interferes with regulatory T cell function
por: Van Wijk, Femke, et al.
Publicado: (2011)

Thyroid-Stimulatory Antibody as a Predictive Factor for Graves’ Disease Relapse
por: Da Silva Santos, Tiago, et al.
Publicado: (2022)

Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2021)

Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory molecules
por: Bech, Rikke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rnmlegg0jphaf7dcn93j3vp8s5